Anbio Biotechnology (NNNN) Shareholders’ equity 2022–2025
Anbio Biotechnology (NNNN) shareholders’ equity at each fiscal year-end, per SEC filings.
$30.2MFY2025 · since FY2022: $12.5M → $30.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $30.2M | +75.4% |
| FY2024 | $17.2M | +16.0% |
| FY2023 | $14.8M | +18.1% |
| FY2022 | $12.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice